目的 了解注射用丹參多酚酸臨床應用情況，為臨床合理用藥提供參考。方法 采用醫(yī)院集中監(jiān)測方法選取吉林大學中日聯(lián)誼醫(yī)院2018年8月-2019年4月使用注射用丹參多酚酸的住院患者，從用藥科室、適應癥、療程、給藥劑量、溶媒種類、溶媒體積、給藥頻次、滴速、是否沖管、合并用藥等方面進行統(tǒng)計分析。結果 2 000例用藥者中適應癥不適宜占20.25%，選用溶媒不適宜占0.2%，溶媒體積不適宜占0.05%，療程不足占96.3%，超療程用藥占1.35%，未標注滴速占29.35%，未沖管占29.95%，合并用藥占47.95%，交替用藥占36.8%，重復用藥占1.85%，不良反應發(fā)生率為0.2%。結論 注射用丹參多酚酸安全性良好，臨床使用中存在療程不足及超適應癥用藥現(xiàn)象，應加強管理。

Objective To understand the clinical application of Salvianolic Acid for Injection, and provide reference for clinical rational use. Methods The hospital centralized monitoring method was used to select inpatients who used Salvianolic Acid for Injection from August 2018 to April 2019 in China-Japan Union Hospital of Jilin University. Statistical analysis was performed from the medication department, indications, course of treatment, dose of administration, types and volume of solvent media, frequency of administration, dropping speed, flushing, combined medication, etc. Results In 2 000 cases, the indication was not suitable for 20.25%, the solvent was not suitable for 0.2%, the dissolution media was not suitable for 0.05%, the treatment was insufficient for 96.3%, the overdose of course of treatment was 1.35%, the unlabeled dropping rate was 29.35%, and the untreated tube was 29.95%. The combined medication was 47.95%, the alternating medication was 36.8%, the repeated medication was 1.85%, and the incidence of adverse reactions was 0.2%. Conclusion The safety of Salvianolic Acid for Injection is good, and there are insufficient treatment courses and over-indications in clinical use, and management should be strengthened.